DeepCure
's headquarters is in Boston, Massachusetts. Kfir Schreiber is the Co-Founder & CEO of DeepCure. DeepCure's latest funding round was a Series A for $24.6M on Apr 2024. DeepCure has 2 followers on Owler.DeepCure
's headquarters is in Boston, Massachusetts. Kfir Schreiber is the Co-Founder & CEO of DeepCure. DeepCure's latest funding round was a Series A for $24.6M on Apr 2024. DeepCure has 2 followers on Owler.
News
Dec 19, 2024
Business Wire
Press Release: DeepCure : DeepCure Unveils STAT6 Inhibitor Program with Novel Oral Small Molecules Targeting Type 2 Inflammation
Oct 03, 2024
FinanzNachrichten
DeepCure: DeepCure to Present In Vivo Data Showing Its Selective BRD4 (BD2) Inhibitor DC-9476 is Superior to Etanercept in Rheumatoid Arthritis
Sep 09, 2024
Drug Discovery & Development
DeepCure: How DeepCure taps reinforcement learning for first-in-class therapies
Aug 19, 2024
Yahoo
DeepCure: DeepCure links with Leeds Institute to bring AI-based RA drug to clinic
Aug 08, 2024
Business Wire
Press Release: DeepCure : DeepCure Announces Selection of First AI-Generated Candidate DC-9476 for Autoimmune Diseases
May 28, 2024
Business Wire
Press Release: DeepCure : DeepCure Turns Complex Drug Designs into Testable Molecules with Robotic Synthesis Breakthrough
May 18, 2024
ExploreBit
DeepCure: DeepCure Closes USD 24M Series A1 Funding
Apr 16, 2024
Pulse2.0
DeepCure: DeepCure: Small Molecule Therapeutics Company Raises $24 Million
Apr 15, 2024
Jewish Business News
DeepCure: Israeli Startup DeepCure Is Developing Medications from Really Small Molecules
Apr 11, 2024
FinSMEs
DeepCure: DeepCure Closes $24M Series A-1 Funding